127 related articles for article (PubMed ID: 38787832)
1. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
[TBL] [Abstract][Full Text] [Related]
2. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI.
Yang WY; Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
J Clin Ultrasound; 2017 Nov; 45(9):542-550. PubMed ID: 28547764
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
4. A study on the inconsistency of arterial phase hypervascularity detection between contrast-enhanced ultrasound using sonazoid and gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid magnetic resonance imaging of hepatocellular carcinoma lesions.
Wang F; Numata K; Chuma M; Miwa H; Moriya S; Ogushi K; Okada M; Otani M; Inayama Y; Maeda S
J Med Ultrason (2001); 2021 Apr; 48(2):215-224. PubMed ID: 33721130
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.
Sugimoto K; Moriyasu F; Saito K; Taira J; Saguchi T; Yoshimura N; Oshiro H; Imai Y; Shiraishi J
J Ultrasound Med; 2012 Apr; 31(4):529-38. PubMed ID: 22441909
[TBL] [Abstract][Full Text] [Related]
6. Combining the Arterial Phase of Contrast-Enhanced Ultrasonography, Gadoxetic Acid-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging in the Diagnosis of Hepatic Nodules ≤20 mm in Patients with Cirrhosis.
Zhou Y; Jing X; Zhang X; Ding J; Wang Y; Zhou H; Zhang Q; Chen Y; Yue W
Ultrasound Med Biol; 2019 Mar; 45(3):693-701. PubMed ID: 30606633
[TBL] [Abstract][Full Text] [Related]
7. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.
Guo D; Wan W; Bai X; Wen R; Peng J; Lin P; Liao W; Huang W; Liu D; Peng Y; Kang T; Yang H; He Y
Abdom Radiol (NY); 2024 May; 49(5):1432-1443. PubMed ID: 38584190
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
Sawatzki M; Meyenberger C; Brand S; Semela D
Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
[TBL] [Abstract][Full Text] [Related]
13. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
[TBL] [Abstract][Full Text] [Related]
15. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
Li J; Wang J; Lei L; Yuan G; He S
Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
18. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography.
Bartolotta TV; Taibbi A; Midiri M; Matranga D; Solbiati L; Lagalla R
Invest Radiol; 2011 Feb; 46(2):106-15. PubMed ID: 20938345
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.
Miyamoto Y; Ito T; Takada E; Omoto K; Hirai T; Moriyasu F
AJR Am J Roentgenol; 2014 Apr; 202(4):W400-7. PubMed ID: 24660739
[TBL] [Abstract][Full Text] [Related]
20. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
Kim YK; Kim CS; Han YM; Park G
Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
